These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23665539)

  • 1. Sick but satisfied: the impact of life and health satisfaction on choice between health scenarios.
    Dolan P; Kavetsos G; Tsuchiya A
    J Health Econ; 2013 Jul; 32(4):708-14. PubMed ID: 23665539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences of heart failure patients in daily clinical practice: quality of life or longevity?
    Kraai IH; Vermeulen KM; Luttik ML; Hoekstra T; Jaarsma T; Hillege HL
    Eur J Heart Fail; 2013 Oct; 15(10):1113-21. PubMed ID: 23650130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do time trade-off values fully capture attitudes that are relevant to health-related choices?
    Spencer A; Tomeny E; Mujica-Mota RE; Robinson A; Covey J; Pinto-Prades JL
    Eur J Health Econ; 2019 Jun; 20(4):559-568. PubMed ID: 30596209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice Defines Value: A Predictive Modeling Competition in Health Preference Research.
    Jakubczyk M; Craig BM; Barra M; Groothuis-Oudshoorn CGM; Hartman JD; Huynh E; Ramos-Goñi JM; Stolk EA; Rand K
    Value Health; 2018 Feb; 21(2):229-238. PubMed ID: 29477405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead time TTO: leading to better health state valuations?
    Attema AE; Versteegh MM; Oppe M; Brouwer WB; Stolk EA
    Health Econ; 2013 Apr; 22(4):376-92. PubMed ID: 22396243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocols for time tradeoff valuations of health states worse than dead: a literature review.
    Tilling C; Devlin N; Tsuchiya A; Buckingham K
    Med Decis Making; 2010; 30(5):610-9. PubMed ID: 20068144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Question order sensitivity of subjective well-being measures: focus on life satisfaction, self-rated health, and subjective life expectancy in survey instruments.
    Lee S; McClain C; Webster N; Han S
    Qual Life Res; 2016 Oct; 25(10):2497-2510. PubMed ID: 27138962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments.
    Webb EJD; Meads D; Eskytė I; Ford HL; Bekker HL; Chataway J; Pepper G; Marti J; Okan Y; Pavitt SH; Schmierer K; Manzano A
    Patient; 2020 Oct; 13(5):583-597. PubMed ID: 32588337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic conditions on stated preferences for health.
    Pickard AS; Tawk R; Shaw JW
    Eur J Health Econ; 2013 Aug; 14(4):697-702. PubMed ID: 22941035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the public's preferential attitudes toward end-of-life care options: a role for the threshold technique?
    Trafford Crump R; Llewellyn-Thomas H
    Health Serv Res; 2013 Dec; 48(6 Pt 1):2101-24. PubMed ID: 23444844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences for e-Mental Health Interventions in Germany: A Discrete Choice Experiment.
    Phillips EA; Himmler SF; Schreyögg J
    Value Health; 2021 Mar; 24(3):421-430. PubMed ID: 33641777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is bad living better than good death? Impact of demographic and cultural factors on health state preference.
    Jin X; Liu GG; Luo N; Li H; Guan H; Xie F
    Qual Life Res; 2016 Apr; 25(4):979-86. PubMed ID: 26346987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altruistic Preferences in Time Tradeoff: Consideration of Effects on Others in Health State Valuations.
    Krol M; Attema AE; van Exel J; Brouwer W
    Med Decis Making; 2016 Feb; 36(2):187-98. PubMed ID: 26552410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Predisposing Terminally Ill Cancer Patients' Preferences for Distinct Patterns/States of Life-Sustaining Treatments Over Their Last Six Months.
    Wen FH; Chen JS; Chou WC; Chang WC; Hsieh CH; Tang ST
    J Pain Symptom Manage; 2019 Feb; 57(2):190-198.e2. PubMed ID: 30447386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment.
    Veldwijk J; Johansson JV; Donkers B; de Bekker-Grob EW
    Value Health; 2020 Jul; 23(7):945-952. PubMed ID: 32762997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer preferences for health and nonhealth outcomes of health promotion: results from a discrete choice experiment.
    Alayli-Goebbels AF; Dellaert BG; Knox SA; Ament AJ; Lakerveld J; Bot SD; Nijpels G; Severens JL
    Value Health; 2013; 16(1):114-23. PubMed ID: 23337222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New evidence of preference reversals in health utility measurement.
    Bleichrodt H; Pinto Prades JL
    Health Econ; 2009 Jun; 18(6):713-26. PubMed ID: 18770525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.
    Morel T; Aymé S; Cassiman D; Simoens S; Morgan M; Vandebroek M
    Orphanet J Rare Dis; 2016 May; 11(1):70. PubMed ID: 27225337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.
    Shah K; Mulhern B; Longworth L; Janssen MF
    Value Health; 2016 Jan; 19(1):53-9. PubMed ID: 26797236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.